Skip to main content
. 2021 Mar 6;60(6):685–710. doi: 10.1007/s40262-021-00997-0

Fig. 1.

Fig. 1

Population pharmacokinetic (PK) modeling. incl. including, MIC minimum inhibitory concentration, PD pharmacodynamic, TDM therapeutic drug monitoring. Created with Biorender.com